| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 142 | 2024 | 3533 | 10.510 |
Why?
|
| Heart Defects, Congenital | 101 | 2023 | 4586 | 6.050 |
Why?
|
| Hypoplastic Left Heart Syndrome | 36 | 2023 | 574 | 4.660 |
Why?
|
| Transposition of Great Vessels | 31 | 2023 | 589 | 4.240 |
Why?
|
| Heart Ventricles | 65 | 2023 | 3820 | 4.210 |
Why?
|
| Tricuspid Valve Insufficiency | 15 | 2023 | 349 | 4.170 |
Why?
|
| Fontan Procedure | 38 | 2022 | 779 | 3.670 |
Why?
|
| Pulmonary Valve | 21 | 2024 | 437 | 3.380 |
Why?
|
| Mitral Valve | 34 | 2022 | 1490 | 3.370 |
Why?
|
| Aortic Valve Insufficiency | 22 | 2023 | 579 | 3.320 |
Why?
|
| Heart Valve Prosthesis | 22 | 2022 | 1488 | 3.060 |
Why?
|
| Aortic Valve | 30 | 2022 | 1921 | 2.940 |
Why?
|
| Myocardial Reperfusion Injury | 25 | 2020 | 476 | 2.910 |
Why?
|
| Heart Valve Prosthesis Implantation | 29 | 2022 | 1534 | 2.910 |
Why?
|
| Tetralogy of Fallot | 30 | 2024 | 623 | 2.900 |
Why?
|
| Heart Septal Defects, Ventricular | 26 | 2023 | 488 | 2.810 |
Why?
|
| Heart Septal Defects, Atrial | 20 | 2023 | 478 | 2.440 |
Why?
|
| Heart Valve Diseases | 13 | 2023 | 1072 | 2.410 |
Why?
|
| Heart Septal Defects | 11 | 2024 | 192 | 2.400 |
Why?
|
| Echocardiography, Three-Dimensional | 26 | 2017 | 591 | 2.240 |
Why?
|
| Mitral Valve Insufficiency | 20 | 2022 | 1421 | 2.210 |
Why?
|
| Myocardium | 59 | 2023 | 4776 | 2.180 |
Why?
|
| Myocardial Contraction | 39 | 2018 | 1585 | 2.060 |
Why?
|
| Myocardial Ischemia | 24 | 2023 | 2148 | 1.980 |
Why?
|
| Tricuspid Valve | 16 | 2023 | 403 | 1.940 |
Why?
|
| Ventricular Outflow Obstruction | 15 | 2021 | 272 | 1.820 |
Why?
|
| Thoracic Surgery | 9 | 2023 | 719 | 1.730 |
Why?
|
| Endocardial Fibroelastosis | 9 | 2021 | 56 | 1.700 |
Why?
|
| Infant | 186 | 2024 | 35129 | 1.680 |
Why?
|
| Heart Valves | 9 | 2023 | 291 | 1.650 |
Why?
|
| Reoperation | 57 | 2024 | 4203 | 1.630 |
Why?
|
| Models, Cardiovascular | 18 | 2021 | 996 | 1.620 |
Why?
|
| Ebstein Anomaly | 6 | 2021 | 97 | 1.610 |
Why?
|
| Ventricular Function, Right | 14 | 2021 | 592 | 1.600 |
Why?
|
| Pulmonary Artery | 36 | 2023 | 1912 | 1.530 |
Why?
|
| Robotics | 15 | 2021 | 899 | 1.510 |
Why?
|
| Cardiomegaly | 14 | 2022 | 620 | 1.470 |
Why?
|
| Child, Preschool | 152 | 2022 | 40992 | 1.450 |
Why?
|
| Cardiopulmonary Bypass | 28 | 2020 | 1066 | 1.440 |
Why?
|
| Hypertrophy, Left Ventricular | 14 | 2017 | 859 | 1.440 |
Why?
|
| Heart Neoplasms | 7 | 2021 | 374 | 1.440 |
Why?
|
| Infant, Newborn | 128 | 2023 | 25618 | 1.420 |
Why?
|
| Cardioplegic Solutions | 11 | 2012 | 118 | 1.410 |
Why?
|
| Swine | 51 | 2023 | 5940 | 1.400 |
Why?
|
| Postoperative Complications | 63 | 2021 | 15294 | 1.350 |
Why?
|
| Rabbits | 56 | 2023 | 4892 | 1.320 |
Why?
|
| Pericardium | 11 | 2023 | 667 | 1.300 |
Why?
|
| Heart Arrest, Induced | 13 | 2012 | 355 | 1.270 |
Why?
|
| Norwood Procedures | 7 | 2023 | 182 | 1.270 |
Why?
|
| Child | 159 | 2023 | 77679 | 1.250 |
Why?
|
| Abnormalities, Multiple | 19 | 2017 | 1416 | 1.250 |
Why?
|
| Treatment Outcome | 151 | 2024 | 63119 | 1.240 |
Why?
|
| Cardiac Output, Low | 8 | 2016 | 193 | 1.230 |
Why?
|
| Mitral Valve Stenosis | 9 | 2022 | 376 | 1.200 |
Why?
|
| Surgery, Computer-Assisted | 14 | 2012 | 1018 | 1.190 |
Why?
|
| Ventricular Dysfunction, Right | 11 | 2018 | 582 | 1.190 |
Why?
|
| Mitral Valve Annuloplasty | 4 | 2018 | 143 | 1.160 |
Why?
|
| Aorta, Thoracic | 17 | 2023 | 1082 | 1.120 |
Why?
|
| Mitochondria | 12 | 2023 | 3520 | 1.110 |
Why?
|
| Prosthesis Design | 17 | 2022 | 2110 | 1.100 |
Why?
|
| Hemodynamics | 44 | 2023 | 4199 | 1.090 |
Why?
|
| Heart Transplantation | 26 | 2023 | 3123 | 1.080 |
Why?
|
| Reperfusion Injury | 8 | 2023 | 1026 | 1.080 |
Why?
|
| Ventricular Function, Left | 25 | 2021 | 3669 | 1.040 |
Why?
|
| Bioprosthesis | 8 | 2022 | 596 | 1.030 |
Why?
|
| Calcium | 22 | 2020 | 5757 | 0.980 |
Why?
|
| Retrospective Studies | 158 | 2024 | 77426 | 0.980 |
Why?
|
| Coronary Vessel Anomalies | 7 | 2023 | 314 | 0.980 |
Why?
|
| Fibroma | 4 | 2021 | 212 | 0.950 |
Why?
|
| Heart Bypass, Right | 7 | 2014 | 74 | 0.950 |
Why?
|
| Ventricular Dysfunction, Left | 14 | 2021 | 2072 | 0.950 |
Why?
|
| Cardiovascular Surgical Procedures | 11 | 2021 | 194 | 0.940 |
Why?
|
| Cardiac Valve Annuloplasty | 3 | 2020 | 50 | 0.920 |
Why?
|
| Echocardiography | 39 | 2022 | 5103 | 0.910 |
Why?
|
| Myocardial Reperfusion | 12 | 2004 | 351 | 0.910 |
Why?
|
| Humans | 382 | 2024 | 744220 | 0.890 |
Why?
|
| Stress, Mechanical | 11 | 2019 | 1686 | 0.870 |
Why?
|
| Pulmonary Valve Insufficiency | 7 | 2020 | 151 | 0.860 |
Why?
|
| Protein Kinase C | 8 | 2004 | 1227 | 0.860 |
Why?
|
| Endocardial Cushion Defects | 4 | 2013 | 45 | 0.860 |
Why?
|
| Palliative Care | 24 | 2023 | 3490 | 0.850 |
Why?
|
| Arteriovenous Malformations | 4 | 2012 | 396 | 0.830 |
Why?
|
| Time Factors | 81 | 2021 | 40063 | 0.820 |
Why?
|
| Mitral Valve Prolapse | 2 | 2021 | 231 | 0.800 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 120 | 0.790 |
Why?
|
| Animals | 170 | 2023 | 168788 | 0.790 |
Why?
|
| Ventricular Function | 7 | 2020 | 416 | 0.790 |
Why?
|
| Double Outlet Right Ventricle | 7 | 2022 | 58 | 0.790 |
Why?
|
| Aortic Coarctation | 9 | 2011 | 281 | 0.760 |
Why?
|
| Mitochondria, Muscle | 5 | 2020 | 171 | 0.760 |
Why?
|
| Disease Models, Animal | 39 | 2021 | 18027 | 0.730 |
Why?
|
| Aortic Valve Stenosis | 13 | 2023 | 1965 | 0.730 |
Why?
|
| Heart Septum | 8 | 2009 | 313 | 0.710 |
Why?
|
| Clinical Competence | 9 | 2016 | 4687 | 0.710 |
Why?
|
| Histidine | 7 | 1999 | 313 | 0.710 |
Why?
|
| Heart | 31 | 2023 | 4465 | 0.690 |
Why?
|
| Extracorporeal Membrane Oxygenation | 19 | 2022 | 1356 | 0.670 |
Why?
|
| Pacemaker, Artificial | 3 | 2023 | 818 | 0.670 |
Why?
|
| Biomedical Engineering | 1 | 2020 | 296 | 0.670 |
Why?
|
| Computer Simulation | 10 | 2018 | 6196 | 0.670 |
Why?
|
| Cardiotonic Agents | 7 | 2016 | 535 | 0.670 |
Why?
|
| Truncus Arteriosus, Persistent | 6 | 2023 | 63 | 0.650 |
Why?
|
| Oxygenators | 1 | 2018 | 34 | 0.640 |
Why?
|
| Heart-Lung Machine | 1 | 2018 | 43 | 0.640 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2017 | 1132 | 0.630 |
Why?
|
| Adolescent | 97 | 2023 | 85759 | 0.620 |
Why?
|
| Jugular Veins | 2 | 2016 | 204 | 0.620 |
Why?
|
| Pulmonary Veins | 7 | 2022 | 761 | 0.610 |
Why?
|
| Length of Stay | 19 | 2022 | 6308 | 0.610 |
Why?
|
| Male | 201 | 2023 | 350027 | 0.610 |
Why?
|
| Coronary Circulation | 14 | 2019 | 1573 | 0.610 |
Why?
|
| Monosaccharide Transport Proteins | 5 | 2005 | 440 | 0.610 |
Why?
|
| Heating | 1 | 2018 | 97 | 0.600 |
Why?
|
| Water Microbiology | 1 | 2018 | 117 | 0.600 |
Why?
|
| Organ Preservation | 5 | 2018 | 331 | 0.590 |
Why?
|
| Pulmonary Atresia | 11 | 2023 | 160 | 0.590 |
Why?
|
| Quality Indicators, Health Care | 5 | 2014 | 1831 | 0.590 |
Why?
|
| Monitoring, Intraoperative | 4 | 2018 | 953 | 0.580 |
Why?
|
| Myocytes, Cardiac | 10 | 2021 | 1637 | 0.580 |
Why?
|
| Venous Valves | 1 | 2016 | 13 | 0.570 |
Why?
|
| Mitochondria, Heart | 5 | 2022 | 247 | 0.570 |
Why?
|
| Equipment Contamination | 1 | 2018 | 185 | 0.570 |
Why?
|
| Female | 202 | 2023 | 380197 | 0.570 |
Why?
|
| Water Supply | 1 | 2018 | 214 | 0.570 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2016 | 342 | 0.570 |
Why?
|
| Aortic Stenosis, Supravalvular | 3 | 2019 | 30 | 0.560 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 130 | 0.560 |
Why?
|
| Aorta | 12 | 2023 | 2061 | 0.550 |
Why?
|
| Models, Anatomic | 5 | 2016 | 690 | 0.550 |
Why?
|
| Endocardium | 6 | 2022 | 263 | 0.540 |
Why?
|
| Stroke Volume | 17 | 2021 | 5008 | 0.540 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 87 | 0.540 |
Why?
|
| Follow-Up Studies | 63 | 2023 | 39045 | 0.540 |
Why?
|
| Ultrasonography, Interventional | 8 | 2010 | 1483 | 0.530 |
Why?
|
| Suture Techniques | 6 | 2012 | 798 | 0.520 |
Why?
|
| Transplantation | 1 | 2017 | 217 | 0.520 |
Why?
|
| Philosophy, Medical | 1 | 2015 | 79 | 0.520 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2012 | 62 | 0.520 |
Why?
|
| Aftercare | 9 | 2023 | 866 | 0.520 |
Why?
|
| Apoptosis | 9 | 2023 | 9728 | 0.510 |
Why?
|
| Ventricular Remodeling | 6 | 2020 | 1224 | 0.510 |
Why?
|
| Recovery of Function | 15 | 2020 | 2925 | 0.510 |
Why?
|
| Equipment Design | 16 | 2018 | 3582 | 0.500 |
Why?
|
| Risk Assessment | 31 | 2021 | 23337 | 0.500 |
Why?
|
| Hospital Mortality | 12 | 2020 | 5316 | 0.490 |
Why?
|
| Cardiology | 4 | 2016 | 1668 | 0.490 |
Why?
|
| Papillary Muscles | 4 | 2023 | 203 | 0.480 |
Why?
|
| Pulmonary Valve Stenosis | 5 | 2023 | 183 | 0.480 |
Why?
|
| Perfusion | 11 | 2023 | 1359 | 0.480 |
Why?
|
| Glycolysis | 7 | 2007 | 826 | 0.470 |
Why?
|
| Dopamine | 4 | 2009 | 1591 | 0.470 |
Why?
|
| Intraoperative Care | 5 | 2011 | 767 | 0.460 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 2012 | 209 | 0.460 |
Why?
|
| Echocardiography, Doppler, Color | 8 | 2019 | 364 | 0.460 |
Why?
|
| Ventricular Pressure | 11 | 2019 | 199 | 0.460 |
Why?
|
| Patient Discharge | 11 | 2023 | 3313 | 0.460 |
Why?
|
| Animals, Newborn | 19 | 2017 | 2726 | 0.450 |
Why?
|
| Endoscopy | 4 | 2017 | 1784 | 0.450 |
Why?
|
| Catheterization | 10 | 2011 | 1469 | 0.450 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2017 | 3506 | 0.450 |
Why?
|
| Aortic Diseases | 3 | 2023 | 742 | 0.450 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2005 | 282 | 0.450 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 1151 | 0.450 |
Why?
|
| Boston | 21 | 2017 | 9311 | 0.430 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2011 | 4044 | 0.420 |
Why?
|
| Risk Factors | 60 | 2023 | 72280 | 0.420 |
Why?
|
| Tissue Adhesives | 1 | 2014 | 179 | 0.420 |
Why?
|
| Heart Failure | 13 | 2022 | 10905 | 0.420 |
Why?
|
| Coronary Vessels | 10 | 2016 | 3107 | 0.420 |
Why?
|
| Marketing of Health Services | 1 | 2013 | 153 | 0.420 |
Why?
|
| Glycoproteins | 1 | 2020 | 2263 | 0.410 |
Why?
|
| Cardiac Pacing, Artificial | 8 | 2015 | 846 | 0.410 |
Why?
|
| Carotid Arteries | 2 | 2014 | 952 | 0.410 |
Why?
|
| Heart Diseases | 10 | 2012 | 2790 | 0.400 |
Why?
|
| Collagen | 4 | 2019 | 2689 | 0.400 |
Why?
|
| Discrete Subaortic Stenosis | 3 | 2020 | 16 | 0.400 |
Why?
|
| Age Factors | 22 | 2020 | 18367 | 0.400 |
Why?
|
| Device Approval | 1 | 2013 | 163 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2018 | 35423 | 0.400 |
Why?
|
| History, 20th Century | 5 | 2020 | 2739 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2020 | 2267 | 0.390 |
Why?
|
| Prosthesis Failure | 7 | 2022 | 1206 | 0.390 |
Why?
|
| Azygos Vein | 1 | 2010 | 21 | 0.390 |
Why?
|
| Operating Rooms | 1 | 2018 | 815 | 0.390 |
Why?
|
| Hepatic Veins | 2 | 2010 | 112 | 0.390 |
Why?
|
| Diastole | 9 | 2019 | 791 | 0.380 |
Why?
|
| Transplantation, Heterotopic | 6 | 2023 | 175 | 0.380 |
Why?
|
| Young Adult | 39 | 2021 | 56436 | 0.380 |
Why?
|
| Hospitals, Pediatric | 3 | 2016 | 1766 | 0.380 |
Why?
|
| Computer-Aided Design | 2 | 2012 | 298 | 0.370 |
Why?
|
| Materials Testing | 6 | 2019 | 867 | 0.370 |
Why?
|
| Endoscopes | 1 | 2011 | 175 | 0.370 |
Why?
|
| Transplantation, Autologous | 8 | 2020 | 2124 | 0.370 |
Why?
|
| Absorbable Implants | 1 | 2012 | 342 | 0.360 |
Why?
|
| Biocompatible Materials | 4 | 2014 | 1736 | 0.360 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2013 | 369 | 0.360 |
Why?
|
| Ultrasonography | 19 | 2014 | 5982 | 0.360 |
Why?
|
| Thoracic Surgery, Video-Assisted | 4 | 2017 | 273 | 0.360 |
Why?
|
| Survival Rate | 25 | 2019 | 12781 | 0.350 |
Why?
|
| Neovascularization, Physiologic | 5 | 2012 | 1351 | 0.350 |
Why?
|
| Heart Atria | 9 | 2009 | 1356 | 0.340 |
Why?
|
| Vascular Surgical Procedures | 8 | 2022 | 1475 | 0.340 |
Why?
|
| Heart Block | 5 | 2022 | 410 | 0.340 |
Why?
|
| Chi-Square Distribution | 7 | 2014 | 3509 | 0.340 |
Why?
|
| Dilatation, Pathologic | 8 | 2023 | 520 | 0.330 |
Why?
|
| Pulmonary Circulation | 9 | 2018 | 739 | 0.330 |
Why?
|
| Tachycardia, Ventricular | 5 | 2022 | 1273 | 0.330 |
Why?
|
| Polyethylene Terephthalates | 3 | 2023 | 116 | 0.330 |
Why?
|
| Cytosol | 6 | 2009 | 901 | 0.330 |
Why?
|
| Cross Infection | 1 | 2018 | 1416 | 0.330 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2382 | 0.330 |
Why?
|
| Cattle | 7 | 2023 | 3922 | 0.320 |
Why?
|
| Sternum | 4 | 2007 | 177 | 0.320 |
Why?
|
| Postoperative Care | 10 | 2015 | 1485 | 0.320 |
Why?
|
| Video Recording | 2 | 2011 | 947 | 0.320 |
Why?
|
| Ventricular Septum | 3 | 2021 | 73 | 0.320 |
Why?
|
| Biological Products | 1 | 2017 | 860 | 0.310 |
Why?
|
| Depth Perception | 1 | 2008 | 94 | 0.310 |
Why?
|
| Contractile Proteins | 2 | 2001 | 246 | 0.310 |
Why?
|
| Thoracoscopy | 2 | 2005 | 178 | 0.300 |
Why?
|
| Fructosediphosphates | 2 | 1998 | 24 | 0.300 |
Why?
|
| Aortic Arch Syndromes | 1 | 2007 | 19 | 0.300 |
Why?
|
| Heart Arrest | 6 | 2022 | 1470 | 0.290 |
Why?
|
| Fluorescent Dyes | 7 | 2004 | 1917 | 0.290 |
Why?
|
| Systole | 6 | 2021 | 957 | 0.290 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2012 | 110 | 0.290 |
Why?
|
| Sus scrofa | 5 | 2019 | 437 | 0.290 |
Why?
|
| Adult | 68 | 2023 | 214035 | 0.280 |
Why?
|
| Feasibility Studies | 9 | 2023 | 5076 | 0.280 |
Why?
|
| Lactic Acid | 10 | 2012 | 1132 | 0.280 |
Why?
|
| Heart Aneurysm | 2 | 2007 | 120 | 0.280 |
Why?
|
| Fetal Heart | 5 | 2015 | 276 | 0.280 |
Why?
|
| Myocardial Stunning | 2 | 2009 | 68 | 0.280 |
Why?
|
| Hypothermia, Induced | 7 | 2008 | 752 | 0.280 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 321 | 0.270 |
Why?
|
| Oximes | 1 | 2007 | 311 | 0.270 |
Why?
|
| Lithium Compounds | 1 | 2007 | 225 | 0.270 |
Why?
|
| Arginine | 3 | 2002 | 944 | 0.260 |
Why?
|
| Survival Analysis | 21 | 2018 | 10250 | 0.260 |
Why?
|
| United States Food and Drug Administration | 1 | 2013 | 1583 | 0.260 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2012 | 66 | 0.260 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 430 | 0.260 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2012 | 8950 | 0.260 |
Why?
|
| Equipment Failure Analysis | 8 | 2013 | 868 | 0.260 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2011 | 63 | 0.260 |
Why?
|
| Heart-Assist Devices | 4 | 2022 | 1196 | 0.250 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 1971 | 0.250 |
Why?
|
| Troponin I | 4 | 2016 | 619 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 16 | 2017 | 6535 | 0.250 |
Why?
|
| Polytetrafluoroethylene | 2 | 2021 | 233 | 0.250 |
Why?
|
| Energy Metabolism | 10 | 2017 | 2895 | 0.250 |
Why?
|
| Electrocardiography | 6 | 2023 | 6442 | 0.250 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 780 | 0.250 |
Why?
|
| Severity of Illness Index | 18 | 2016 | 15538 | 0.240 |
Why?
|
| Diacetyl | 2 | 2009 | 21 | 0.240 |
Why?
|
| Constriction, Pathologic | 8 | 2022 | 1107 | 0.240 |
Why?
|
| Scimitar Syndrome | 2 | 2022 | 31 | 0.240 |
Why?
|
| Ischemic Preconditioning | 1 | 2004 | 92 | 0.240 |
Why?
|
| Tacrolimus | 3 | 2005 | 743 | 0.240 |
Why?
|
| Spectrometry, Fluorescence | 4 | 2004 | 689 | 0.240 |
Why?
|
| Rats | 20 | 2023 | 24273 | 0.230 |
Why?
|
| Glucose-6-Phosphate | 1 | 2003 | 30 | 0.230 |
Why?
|
| Muscle Proteins | 3 | 2005 | 1159 | 0.230 |
Why?
|
| Task Performance and Analysis | 5 | 2014 | 780 | 0.230 |
Why?
|
| Hemodilution | 4 | 2009 | 114 | 0.230 |
Why?
|
| Ventricular Dysfunction | 3 | 2017 | 143 | 0.230 |
Why?
|
| Vena Cava, Superior | 5 | 2012 | 193 | 0.230 |
Why?
|
| Research Support as Topic | 1 | 2008 | 704 | 0.230 |
Why?
|
| Multivariate Analysis | 15 | 2016 | 12244 | 0.230 |
Why?
|
| Cold Ischemia | 2 | 2018 | 65 | 0.230 |
Why?
|
| Dilatation | 4 | 2023 | 291 | 0.230 |
Why?
|
| Subclavian Vein | 1 | 2003 | 54 | 0.230 |
Why?
|
| Glucose | 8 | 2005 | 4396 | 0.230 |
Why?
|
| Pressure | 5 | 2014 | 1203 | 0.230 |
Why?
|
| Logistic Models | 13 | 2016 | 13409 | 0.230 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 417 | 0.230 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 391 | 0.230 |
Why?
|
| Malus | 1 | 2023 | 48 | 0.220 |
Why?
|
| Aneurysm, False | 2 | 2004 | 276 | 0.220 |
Why?
|
| Cyclosporine | 3 | 2005 | 786 | 0.220 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 1005 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 9 | 2003 | 2557 | 0.220 |
Why?
|
| Thoracotomy | 3 | 2017 | 363 | 0.220 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2015 | 3328 | 0.220 |
Why?
|
| Video-Assisted Surgery | 1 | 2003 | 51 | 0.220 |
Why?
|
| Amiloride | 2 | 2002 | 121 | 0.220 |
Why?
|
| Blood Vessel Prosthesis Implantation | 5 | 2014 | 1390 | 0.220 |
Why?
|
| Elasticity | 3 | 2014 | 657 | 0.210 |
Why?
|
| History, 21st Century | 2 | 2020 | 1534 | 0.210 |
Why?
|
| Image Enhancement | 7 | 2019 | 2921 | 0.210 |
Why?
|
| Muscle Cells | 3 | 2009 | 196 | 0.210 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2001 | 123 | 0.210 |
Why?
|
| Models, Animal | 5 | 2016 | 2171 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 3 | 2016 | 7281 | 0.210 |
Why?
|
| Heart, Artificial | 1 | 2022 | 102 | 0.210 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 44 | 0.210 |
Why?
|
| Intestinal Volvulus | 1 | 2022 | 65 | 0.200 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2001 | 67 | 0.200 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2211 | 0.200 |
Why?
|
| Arteries | 2 | 2023 | 1119 | 0.200 |
Why?
|
| Disease Progression | 16 | 2022 | 13280 | 0.200 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 292 | 0.200 |
Why?
|
| Intensive Care Units | 3 | 2013 | 3680 | 0.200 |
Why?
|
| Bronchiectasis | 1 | 2022 | 128 | 0.200 |
Why?
|
| Oxygen Consumption | 9 | 2005 | 1869 | 0.200 |
Why?
|
| Blood Pressure | 11 | 2023 | 8551 | 0.200 |
Why?
|
| Adenosine Triphosphate | 12 | 2002 | 2025 | 0.190 |
Why?
|
| Phosphatidylinositols | 1 | 2002 | 291 | 0.190 |
Why?
|
| Hematocrit | 5 | 2010 | 636 | 0.190 |
Why?
|
| Indoles | 2 | 2007 | 1838 | 0.190 |
Why?
|
| Fetal Diseases | 4 | 2014 | 903 | 0.190 |
Why?
|
| Surgical Instruments | 5 | 2007 | 395 | 0.190 |
Why?
|
| Algorithms | 11 | 2019 | 13885 | 0.190 |
Why?
|
| Blood Vessel Prosthesis | 5 | 2014 | 933 | 0.190 |
Why?
|
| Isoenzymes | 3 | 2002 | 1726 | 0.190 |
Why?
|
| Recurrence | 11 | 2020 | 8343 | 0.190 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 182 | 0.190 |
Why?
|
| Propofol | 1 | 2006 | 628 | 0.180 |
Why?
|
| Cardiovascular Abnormalities | 3 | 2006 | 144 | 0.180 |
Why?
|
| Probability | 10 | 2008 | 2505 | 0.180 |
Why?
|
| Neuregulin-1 | 1 | 2021 | 142 | 0.180 |
Why?
|
| Lactates | 5 | 1995 | 432 | 0.180 |
Why?
|
| Elastin | 3 | 2019 | 308 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2021 | 964 | 0.180 |
Why?
|
| Tissue Donors | 4 | 2023 | 2242 | 0.180 |
Why?
|
| Calpain | 1 | 2020 | 150 | 0.170 |
Why?
|
| Odds Ratio | 6 | 2016 | 9849 | 0.170 |
Why?
|
| Pulsatile Flow | 2 | 2011 | 332 | 0.170 |
Why?
|
| Predictive Value of Tests | 12 | 2018 | 15070 | 0.170 |
Why?
|
| Rats, Wistar | 6 | 2014 | 1903 | 0.170 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2020 | 57 | 0.170 |
Why?
|
| Rats, Inbred Lew | 4 | 2016 | 1161 | 0.170 |
Why?
|
| Analysis of Variance | 9 | 2017 | 6367 | 0.170 |
Why?
|
| Blood Flow Velocity | 6 | 2018 | 1423 | 0.170 |
Why?
|
| Nervous System | 1 | 2002 | 554 | 0.170 |
Why?
|
| Organ Culture Techniques | 4 | 2013 | 813 | 0.170 |
Why?
|
| Diuretics | 1 | 2002 | 592 | 0.170 |
Why?
|
| Postoperative Period | 8 | 2011 | 1841 | 0.170 |
Why?
|
| Data Display | 3 | 2009 | 182 | 0.160 |
Why?
|
| Renal Artery | 1 | 2021 | 398 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1240 | 0.160 |
Why?
|
| Preoperative Care | 9 | 2014 | 2246 | 0.160 |
Why?
|
| Fibrosis | 4 | 2020 | 2029 | 0.160 |
Why?
|
| Dogs | 11 | 2004 | 3913 | 0.160 |
Why?
|
| Ligation | 5 | 2013 | 453 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2001 | 406 | 0.160 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 5 | 2004 | 215 | 0.160 |
Why?
|
| Developmental Disabilities | 4 | 2008 | 1456 | 0.160 |
Why?
|
| Hydrogels | 1 | 2023 | 724 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2015 | 1695 | 0.150 |
Why?
|
| Tissue Fixation | 1 | 2019 | 241 | 0.150 |
Why?
|
| Organ Size | 5 | 2014 | 2252 | 0.150 |
Why?
|
| Stem Cells | 5 | 2023 | 3567 | 0.150 |
Why?
|
| Treatment Failure | 5 | 2021 | 2619 | 0.150 |
Why?
|
| Blood | 3 | 2014 | 598 | 0.150 |
Why?
|
| Subclavian Artery | 3 | 2007 | 129 | 0.150 |
Why?
|
| Prospective Studies | 18 | 2021 | 53280 | 0.150 |
Why?
|
| Statistics, Nonparametric | 6 | 2008 | 2886 | 0.150 |
Why?
|
| Aortic Aneurysm | 2 | 2016 | 643 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1265 | 0.150 |
Why?
|
| Disease-Free Survival | 8 | 2015 | 6893 | 0.150 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 526 | 0.150 |
Why?
|
| Glutaral | 1 | 2017 | 78 | 0.150 |
Why?
|
| Capillaries | 3 | 2010 | 774 | 0.150 |
Why?
|
| Situs Inversus | 2 | 2010 | 64 | 0.150 |
Why?
|
| Pediatrics | 1 | 2012 | 3469 | 0.140 |
Why?
|
| Calcinosis | 2 | 2017 | 1499 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 1 | 2001 | 850 | 0.140 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2021 | 713 | 0.140 |
Why?
|
| Anisotropy | 2 | 2012 | 1265 | 0.140 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2021 | 793 | 0.140 |
Why?
|
| Alanine | 2 | 2001 | 572 | 0.140 |
Why?
|
| Prognosis | 13 | 2023 | 29050 | 0.140 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1741 | 0.140 |
Why?
|
| Finite Element Analysis | 2 | 2015 | 431 | 0.140 |
Why?
|
| Chronic Disease | 5 | 2013 | 9147 | 0.130 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1999 | 851 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2014 | 4419 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2002 | 794 | 0.130 |
Why?
|
| Ice | 1 | 1996 | 104 | 0.130 |
Why?
|
| Isoantigens | 1 | 2018 | 567 | 0.130 |
Why?
|
| Reproducibility of Results | 15 | 2019 | 19907 | 0.130 |
Why?
|
| Adenosine | 2 | 1997 | 825 | 0.130 |
Why?
|
| Constriction | 3 | 2012 | 181 | 0.130 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 98 | 0.130 |
Why?
|
| Aerosols | 1 | 2018 | 623 | 0.130 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 688 | 0.130 |
Why?
|
| Aprotinin | 1 | 2015 | 88 | 0.130 |
Why?
|
| Prostheses and Implants | 5 | 2009 | 1387 | 0.130 |
Why?
|
| Angioplasty, Balloon | 2 | 2011 | 653 | 0.130 |
Why?
|
| Rewarming | 1 | 2015 | 61 | 0.130 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2014 | 22 | 0.130 |
Why?
|
| Life Tables | 5 | 2006 | 370 | 0.130 |
Why?
|
| Endothelins | 1 | 1995 | 138 | 0.130 |
Why?
|
| Anniversaries and Special Events | 1 | 2015 | 89 | 0.120 |
Why?
|
| Assisted Circulation | 1 | 1994 | 104 | 0.120 |
Why?
|
| Computer Systems | 5 | 2011 | 483 | 0.120 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 11728 | 0.120 |
Why?
|
| Stents | 3 | 2012 | 3280 | 0.120 |
Why?
|
| Patient Selection | 6 | 2020 | 4216 | 0.120 |
Why?
|
| Diffusion of Innovation | 2 | 2016 | 725 | 0.120 |
Why?
|
| Aortopulmonary Septal Defect | 2 | 2006 | 7 | 0.120 |
Why?
|
| Morbidity | 3 | 2017 | 1769 | 0.120 |
Why?
|
| Oxygen | 6 | 2009 | 4187 | 0.120 |
Why?
|
| Sensitivity and Specificity | 12 | 2011 | 14726 | 0.120 |
Why?
|
| Defibrillators, Implantable | 2 | 2022 | 1440 | 0.120 |
Why?
|
| Surgical Fixation Devices | 1 | 2013 | 7 | 0.120 |
Why?
|
| Benzophenanthridines | 3 | 2002 | 27 | 0.120 |
Why?
|
| Nerve Block | 1 | 2020 | 642 | 0.120 |
Why?
|
| Proportional Hazards Models | 12 | 2017 | 12355 | 0.120 |
Why?
|
| Phenanthridines | 3 | 2002 | 51 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 171 | 0.120 |
Why?
|
| Heart Conduction System | 3 | 2010 | 1047 | 0.120 |
Why?
|
| Phosphorylation | 7 | 2010 | 8437 | 0.120 |
Why?
|
| Nitroglycerin | 1 | 1995 | 325 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 795 | 0.120 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2005 | 250 | 0.120 |
Why?
|
| Random Allocation | 3 | 2008 | 2427 | 0.120 |
Why?
|
| Middle Aged | 22 | 2021 | 213367 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1312 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2001 | 2014 | 0.110 |
Why?
|
| Linear Models | 2 | 2014 | 5953 | 0.110 |
Why?
|
| Hypothermia | 1 | 2015 | 189 | 0.110 |
Why?
|
| Myocarditis | 3 | 2009 | 771 | 0.110 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 146 | 0.110 |
Why?
|
| Patient Readmission | 2 | 2019 | 3114 | 0.110 |
Why?
|
| Bronchial Diseases | 1 | 1994 | 151 | 0.110 |
Why?
|
| Fluoroscopy | 4 | 2013 | 924 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2005 | 3701 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2014 | 249 | 0.110 |
Why?
|
| Magnesium | 2 | 1995 | 813 | 0.110 |
Why?
|
| History, 19th Century | 1 | 2015 | 720 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2016 | 531 | 0.110 |
Why?
|
| Ventricular Premature Complexes | 1 | 2013 | 111 | 0.110 |
Why?
|
| Massachusetts | 3 | 2017 | 8663 | 0.110 |
Why?
|
| Cohort Studies | 15 | 2019 | 40559 | 0.110 |
Why?
|
| Elastomers | 1 | 2012 | 71 | 0.110 |
Why?
|
| Immunoblotting | 4 | 2006 | 1682 | 0.110 |
Why?
|
| Antifibrinolytic Agents | 1 | 2015 | 254 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5396 | 0.110 |
Why?
|
| Alkaloids | 3 | 2002 | 190 | 0.110 |
Why?
|
| Catheters | 1 | 2015 | 425 | 0.100 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1880 | 0.100 |
Why?
|
| Insulin | 2 | 2005 | 6583 | 0.100 |
Why?
|
| Watchful Waiting | 1 | 2016 | 491 | 0.100 |
Why?
|
| Blood Coagulation Factors | 3 | 2003 | 355 | 0.100 |
Why?
|
| Transplantation, Homologous | 3 | 2018 | 4776 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.100 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2012 | 125 | 0.100 |
Why?
|
| Pennsylvania | 2 | 2012 | 612 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2020 | 1058 | 0.100 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 1076 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 1995 | 597 | 0.100 |
Why?
|
| Coronary Artery Bypass | 3 | 1999 | 2289 | 0.100 |
Why?
|
| Models, Biological | 2 | 2008 | 9582 | 0.100 |
Why?
|
| Interleukin-2 | 2 | 1996 | 1904 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2010 | 5180 | 0.100 |
Why?
|
| Body Temperature | 1 | 2015 | 777 | 0.100 |
Why?
|
| Aorta, Abdominal | 2 | 2013 | 645 | 0.100 |
Why?
|
| Mesoderm | 1 | 2015 | 686 | 0.100 |
Why?
|
| Alloys | 1 | 2011 | 122 | 0.100 |
Why?
|
| Amrinone | 2 | 2002 | 14 | 0.100 |
Why?
|
| Deglutition Disorders | 3 | 2007 | 605 | 0.100 |
Why?
|
| Dextrocardia | 1 | 2010 | 37 | 0.100 |
Why?
|
| Echocardiography, Doppler | 5 | 2009 | 934 | 0.100 |
Why?
|
| Child Welfare | 3 | 2012 | 523 | 0.100 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2011 | 143 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 1 | 2003 | 1875 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 5529 | 0.100 |
Why?
|
| Vena Cava, Inferior | 3 | 2005 | 436 | 0.100 |
Why?
|
| Atrial Function | 1 | 2011 | 107 | 0.100 |
Why?
|
| Altitude | 1 | 2011 | 161 | 0.090 |
Why?
|
| Enzyme Inhibitors | 6 | 2009 | 3800 | 0.090 |
Why?
|
| Infant Mortality | 2 | 2012 | 754 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 950 | 0.090 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 223 | 0.090 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2009 | 76 | 0.090 |
Why?
|
| Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2010 | 978 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 4 | 2012 | 1536 | 0.090 |
Why?
|
| Cardiomyopathies | 5 | 1996 | 1913 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2010 | 552 | 0.090 |
Why?
|
| Nitric Oxide | 5 | 2005 | 2131 | 0.090 |
Why?
|
| Endotoxemia | 3 | 2000 | 206 | 0.090 |
Why?
|
| Heart Rate | 2 | 2012 | 4092 | 0.090 |
Why?
|
| Program Development | 1 | 2016 | 1315 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1411 | 0.090 |
Why?
|
| Child Mortality | 1 | 2012 | 198 | 0.090 |
Why?
|
| Epithelium | 1 | 2015 | 1680 | 0.090 |
Why?
|
| Autoimmune Diseases | 3 | 2009 | 2136 | 0.090 |
Why?
|
| Cell Transplantation | 3 | 2006 | 477 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2002 | 215 | 0.090 |
Why?
|
| Heart Function Tests | 2 | 2007 | 330 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2013 | 315 | 0.090 |
Why?
|
| Quality Improvement | 2 | 2016 | 3746 | 0.090 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2009 | 45 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2003 | 3863 | 0.090 |
Why?
|
| STAT4 Transcription Factor | 1 | 2009 | 96 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 3 | 2009 | 2732 | 0.090 |
Why?
|
| Lung | 5 | 2019 | 9852 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2016 | 1442 | 0.080 |
Why?
|
| Man-Machine Systems | 1 | 2009 | 44 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 638 | 0.080 |
Why?
|
| North America | 1 | 2012 | 1250 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 1998 | 1582 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2007 | 1537 | 0.080 |
Why?
|
| Plasma Substitutes | 1 | 2008 | 57 | 0.080 |
Why?
|
| Cost Savings | 1 | 2014 | 926 | 0.080 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 430 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2009 | 199 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1060 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2009 | 117 | 0.080 |
Why?
|
| Bronchitis | 1 | 2009 | 201 | 0.080 |
Why?
|
| Williams Syndrome | 2 | 2001 | 187 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2021 | 112 | 0.080 |
Why?
|
| Cardiac Volume | 3 | 2003 | 210 | 0.080 |
Why?
|
| Subtraction Technique | 1 | 2011 | 525 | 0.080 |
Why?
|
| Pilot Projects | 4 | 2020 | 8321 | 0.080 |
Why?
|
| Lipopolysaccharides | 6 | 2001 | 2216 | 0.080 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2008 | 16 | 0.080 |
Why?
|
| Infant Welfare | 3 | 2003 | 82 | 0.080 |
Why?
|
| Deoxyglucose | 2 | 2001 | 337 | 0.080 |
Why?
|
| Biological Transport | 3 | 2003 | 2120 | 0.080 |
Why?
|
| Buffers | 3 | 1995 | 147 | 0.080 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 2 | 2009 | 14 | 0.080 |
Why?
|
| Muscle, Skeletal | 3 | 2009 | 4935 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2014 | 984 | 0.080 |
Why?
|
| Cells, Cultured | 10 | 2021 | 19227 | 0.080 |
Why?
|
| Anastomosis, Surgical | 6 | 2007 | 987 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 12075 | 0.080 |
Why?
|
| Brachiocephalic Trunk | 1 | 2007 | 44 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 1677 | 0.080 |
Why?
|
| Transducers | 1 | 2009 | 252 | 0.080 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1988 | 219 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 2291 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1955 | 0.070 |
Why?
|
| Intraoperative Complications | 3 | 2011 | 1195 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20123 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1676 | 0.070 |
Why?
|
| Phosphocreatine | 4 | 2001 | 269 | 0.070 |
Why?
|
| Radiography | 5 | 2012 | 7022 | 0.070 |
Why?
|
| Mice | 13 | 2023 | 81178 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 372 | 0.070 |
Why?
|
| Organic Chemicals | 2 | 2009 | 211 | 0.070 |
Why?
|
| Deferoxamine | 3 | 1992 | 151 | 0.070 |
Why?
|
| Cause of Death | 6 | 2012 | 3584 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4837 | 0.070 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2005 | 61 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 9960 | 0.070 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 99 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 21824 | 0.070 |
Why?
|
| Biopsy | 3 | 2013 | 6757 | 0.070 |
Why?
|
| Photogrammetry | 1 | 2006 | 73 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3611 | 0.070 |
Why?
|
| Intraoperative Period | 1 | 2007 | 520 | 0.070 |
Why?
|
| Oximetry | 1 | 2009 | 469 | 0.070 |
Why?
|
| Remission Induction | 1 | 2011 | 2389 | 0.070 |
Why?
|
| Sorbitol | 1 | 1985 | 59 | 0.070 |
Why?
|
| Procaine | 1 | 1985 | 60 | 0.070 |
Why?
|
| Ischemia | 2 | 2023 | 1914 | 0.070 |
Why?
|
| United States | 8 | 2021 | 69867 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2529 | 0.060 |
Why?
|
| Injections, Intra-Arterial | 2 | 2020 | 193 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 643 | 0.060 |
Why?
|
| Signal Transduction | 8 | 2021 | 23404 | 0.060 |
Why?
|
| Research Design | 2 | 2022 | 5987 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 567 | 0.060 |
Why?
|
| Sex Factors | 3 | 2016 | 10396 | 0.060 |
Why?
|
| Quinolines | 2 | 2000 | 730 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2021 | 11478 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2008 | 805 | 0.060 |
Why?
|
| Surgical Equipment | 1 | 2004 | 57 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 726 | 0.060 |
Why?
|
| Ventricular Fibrillation | 2 | 2022 | 538 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 5 | 2002 | 916 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 441 | 0.060 |
Why?
|
| Wound Healing | 1 | 2015 | 2785 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2002 | 821 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2020 | 548 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6612 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 1432 | 0.060 |
Why?
|
| Propanolamines | 1 | 2004 | 167 | 0.060 |
Why?
|
| Reperfusion | 1 | 2005 | 284 | 0.060 |
Why?
|
| Vascular Resistance | 4 | 2012 | 937 | 0.060 |
Why?
|
| Resuscitation | 1 | 2008 | 657 | 0.060 |
Why?
|
| Polypropylenes | 1 | 2023 | 64 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2016 | 3741 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 721 | 0.060 |
Why?
|
| Necrosis | 3 | 2002 | 1643 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 270 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2005 | 494 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2006 | 256 | 0.060 |
Why?
|
| Dipeptides | 1 | 2005 | 409 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 472 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2018 | 7730 | 0.060 |
Why?
|
| Artificial Intelligence | 2 | 2007 | 2213 | 0.060 |
Why?
|
| Truncus Arteriosus | 1 | 2023 | 22 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 804 | 0.060 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3478 | 0.060 |
Why?
|
| Cardiography, Impedance | 1 | 2003 | 41 | 0.060 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 2796 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2003 | 1504 | 0.060 |
Why?
|
| Inflammation Mediators | 2 | 2010 | 1889 | 0.060 |
Why?
|
| Prolapse | 1 | 2022 | 68 | 0.050 |
Why?
|
| Propranolol | 1 | 2004 | 502 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3036 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2006 | 1372 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 1985 | 576 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2010 | 1000 | 0.050 |
Why?
|
| Estrenes | 1 | 2002 | 23 | 0.050 |
Why?
|
| User-Computer Interface | 2 | 2006 | 1426 | 0.050 |
Why?
|
| Coronary Angiography | 5 | 2018 | 4578 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2002 | 44 | 0.050 |
Why?
|
| Connexin 43 | 1 | 2003 | 207 | 0.050 |
Why?
|
| Caustics | 1 | 2002 | 30 | 0.050 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2003 | 192 | 0.050 |
Why?
|
| Milrinone | 1 | 2002 | 84 | 0.050 |
Why?
|
| Microcirculation | 2 | 2004 | 1286 | 0.050 |
Why?
|
| Diagnostic Imaging | 4 | 2011 | 3508 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2002 | 149 | 0.050 |
Why?
|
| Patient Admission | 2 | 2007 | 1380 | 0.050 |
Why?
|
| Methods | 2 | 1996 | 1128 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2008 | 2970 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2001 | 104 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2003 | 233 | 0.050 |
Why?
|
| Endotoxins | 2 | 2001 | 527 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1849 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 791 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 246 | 0.050 |
Why?
|
| Pyrrolidinones | 1 | 2002 | 117 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2004 | 9735 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2018 | 713 | 0.050 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2004 | 263 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 2 | 2018 | 257 | 0.050 |
Why?
|
| Esophagus | 1 | 2007 | 1018 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4752 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2001 | 127 | 0.050 |
Why?
|
| Pregnancy | 8 | 2023 | 29142 | 0.050 |
Why?
|
| Maleimides | 1 | 2001 | 112 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 7908 | 0.050 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2000 | 12 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 2008 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1620 | 0.050 |
Why?
|
| Graft Rejection | 4 | 1999 | 4399 | 0.050 |
Why?
|
| Forecasting | 3 | 2006 | 2949 | 0.050 |
Why?
|
| Phosphates | 2 | 1995 | 786 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2008 | 2751 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2021 | 683 | 0.050 |
Why?
|
| Rats, Zucker | 1 | 2020 | 128 | 0.050 |
Why?
|
| Gestational Age | 4 | 2014 | 3493 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6489 | 0.050 |
Why?
|
| Free Radicals | 3 | 1989 | 236 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 11732 | 0.040 |
Why?
|
| Immunohistochemistry | 5 | 2009 | 11368 | 0.040 |
Why?
|
| American Heart Association | 3 | 2008 | 1056 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 2001 | 195 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13668 | 0.040 |
Why?
|
| Losartan | 1 | 2021 | 299 | 0.040 |
Why?
|
| Brain Death | 1 | 2023 | 348 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2019 | 767 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2021 | 213 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1185 | 0.040 |
Why?
|
| Troponin | 1 | 2023 | 524 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2002 | 338 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1901 | 0.040 |
Why?
|
| Proteomics | 1 | 2012 | 3637 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2021 | 276 | 0.040 |
Why?
|
| Exercise Tolerance | 3 | 2016 | 770 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2018 | 6386 | 0.040 |
Why?
|
| Thrombophilia | 1 | 2002 | 305 | 0.040 |
Why?
|
| Heparin | 1 | 2006 | 1637 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 139 | 0.040 |
Why?
|
| Tracheal Stenosis | 1 | 2001 | 226 | 0.040 |
Why?
|
| Artifacts | 1 | 2008 | 1903 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2011 | 780 | 0.040 |
Why?
|
| Endothelium, Vascular | 3 | 2003 | 4455 | 0.040 |
Why?
|
| Phosphorus Isotopes | 1 | 1998 | 126 | 0.040 |
Why?
|
| Polyesters | 2 | 2011 | 363 | 0.040 |
Why?
|
| Comorbidity | 2 | 2012 | 10387 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2009 | 3085 | 0.040 |
Why?
|
| Digitonin | 1 | 1998 | 27 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2503 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2006 | 1175 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2001 | 1971 | 0.040 |
Why?
|
| Superantigens | 1 | 1998 | 129 | 0.040 |
Why?
|
| Metals | 2 | 2013 | 719 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2636 | 0.040 |
Why?
|
| Mice, Inbred mdx | 2 | 2009 | 90 | 0.040 |
Why?
|
| Calcimycin | 1 | 1998 | 222 | 0.040 |
Why?
|
| Ionophores | 1 | 1998 | 108 | 0.040 |
Why?
|
| Inflammation | 4 | 2014 | 10634 | 0.040 |
Why?
|
| Potassium Compounds | 1 | 1997 | 40 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 148 | 0.040 |
Why?
|
| Research | 2 | 2005 | 1999 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2001 | 3760 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2002 | 1791 | 0.040 |
Why?
|
| Bradykinin | 1 | 1998 | 214 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 424 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5096 | 0.040 |
Why?
|
| Hindlimb | 1 | 2019 | 505 | 0.040 |
Why?
|
| Lysine | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Cell Respiration | 1 | 2017 | 200 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4151 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2019 | 390 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 795 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 185 | 0.040 |
Why?
|
| Endocytosis | 2 | 2017 | 985 | 0.040 |
Why?
|
| Serine | 1 | 2001 | 828 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2010 | 546 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15161 | 0.040 |
Why?
|
| Cisplatin | 1 | 2023 | 1642 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 1267 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2374 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2002 | 819 | 0.040 |
Why?
|
| Lysosomes | 2 | 2017 | 893 | 0.040 |
Why?
|
| Collateral Circulation | 2 | 2003 | 287 | 0.030 |
Why?
|
| Observer Variation | 2 | 2018 | 2593 | 0.030 |
Why?
|
| Body Weight | 1 | 2007 | 4666 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1992 | 1574 | 0.030 |
Why?
|
| Raffinose | 1 | 1995 | 52 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2016 | 214 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 590 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 610 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1782 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2019 | 380 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2003 | 2078 | 0.030 |
Why?
|
| Cadaver | 1 | 2020 | 1337 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1999 | 1263 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4385 | 0.030 |
Why?
|
| Cytokines | 3 | 2019 | 7326 | 0.030 |
Why?
|
| Binding Sites | 2 | 2002 | 6116 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1618 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 969 | 0.030 |
Why?
|
| Lentivirus | 2 | 2009 | 501 | 0.030 |
Why?
|
| Manganese | 1 | 1998 | 408 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2002 | 534 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1994 | 81 | 0.030 |
Why?
|
| Endosomes | 1 | 2017 | 520 | 0.030 |
Why?
|
| Surgical Flaps | 1 | 2003 | 1640 | 0.030 |
Why?
|
| Longevity | 1 | 2022 | 1069 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2009 | 913 | 0.030 |
Why?
|
| Coronary Disease | 5 | 1990 | 6078 | 0.030 |
Why?
|
| Planning Techniques | 1 | 2014 | 82 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 390 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1392 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6474 | 0.030 |
Why?
|
| Prostate | 1 | 2023 | 1773 | 0.030 |
Why?
|
| Aging | 3 | 2010 | 8661 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 191 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2022 | 1677 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2014 | 72 | 0.030 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 518 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2009 | 3203 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 1999 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 1993 | 140 | 0.030 |
Why?
|
| Incidence | 3 | 2008 | 20945 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2015 | 252 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1999 | 611 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 1001 | 0.030 |
Why?
|
| Auscultation | 1 | 2013 | 42 | 0.030 |
Why?
|
| Foreign-Body Reaction | 1 | 2014 | 157 | 0.030 |
Why?
|
| Adenine Nucleotides | 2 | 1992 | 121 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 1993 | 162 | 0.030 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2013 | 42 | 0.030 |
Why?
|
| Thrombosis | 2 | 2006 | 2968 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 588 | 0.030 |
Why?
|
| Decanoates | 1 | 2012 | 54 | 0.030 |
Why?
|
| Replantation | 1 | 2014 | 148 | 0.030 |
Why?
|
| Heart Massage | 1 | 1992 | 30 | 0.030 |
Why?
|
| Angiostatins | 1 | 2012 | 67 | 0.030 |
Why?
|
| ROC Curve | 2 | 2015 | 3527 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1789 | 0.030 |
Why?
|
| Spleen | 2 | 2009 | 2361 | 0.030 |
Why?
|
| Venous Pressure | 1 | 2012 | 56 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2014 | 13036 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 2088 | 0.030 |
Why?
|
| Bolivia | 1 | 2011 | 19 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2015 | 2569 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1995 | 909 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2011 | 43 | 0.030 |
Why?
|
| Endostatins | 1 | 2012 | 174 | 0.030 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 378 | 0.030 |
Why?
|
| Pre-Excitation Syndromes | 1 | 2011 | 27 | 0.030 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2006 | 277 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2012 | 140 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2001 | 2938 | 0.030 |
Why?
|
| Toxoplasmosis | 1 | 1992 | 91 | 0.030 |
Why?
|
| Sheep | 3 | 1999 | 1437 | 0.030 |
Why?
|
| Mass Screening | 1 | 2007 | 5252 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2012 | 169 | 0.030 |
Why?
|
| Glycerol | 1 | 2012 | 278 | 0.030 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 57 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2012 | 288 | 0.020 |
Why?
|
| Infusions, Intravenous | 3 | 2005 | 2272 | 0.020 |
Why?
|
| Angiography | 2 | 2003 | 1638 | 0.020 |
Why?
|
| Therapeutics | 1 | 2011 | 116 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2012 | 406 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2006 | 4599 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Argentina | 1 | 2011 | 232 | 0.020 |
Why?
|
| Phosphorus | 1 | 1992 | 338 | 0.020 |
Why?
|
| Intracellular Fluid | 2 | 2001 | 203 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1995 | 1539 | 0.020 |
Why?
|
| Myxoma | 1 | 2011 | 130 | 0.020 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 1991 | 80 | 0.020 |
Why?
|
| Acute Disease | 2 | 2019 | 7148 | 0.020 |
Why?
|
| Succinate Dehydrogenase | 1 | 2011 | 146 | 0.020 |
Why?
|
| Fura-2 | 1 | 1990 | 109 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2015 | 21752 | 0.020 |
Why?
|
| Cell Line | 3 | 2017 | 15999 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2010 | 979 | 0.020 |
Why?
|
| Shear Strength | 1 | 2011 | 165 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1640 | 0.020 |
Why?
|
| Cardiac Output | 2 | 2005 | 854 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 907 | 0.020 |
Why?
|
| Benzofurans | 1 | 1990 | 140 | 0.020 |
Why?
|
| Homeostasis | 1 | 2001 | 3339 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Vancomycin | 1 | 1993 | 501 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2011 | 221 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 1990 | 216 | 0.020 |
Why?
|
| Diltiazem | 1 | 1990 | 133 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 2187 | 0.020 |
Why?
|
| Cell Division | 1 | 1997 | 4567 | 0.020 |
Why?
|
| Lipid Peroxides | 1 | 1989 | 73 | 0.020 |
Why?
|
| Pregnancy Proteins | 1 | 2010 | 229 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 683 | 0.020 |
Why?
|
| Head | 1 | 2015 | 880 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10949 | 0.020 |
Why?
|
| Birth Weight | 1 | 2017 | 2069 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 710 | 0.020 |
Why?
|
| Neuropsychological Tests | 3 | 2008 | 6991 | 0.020 |
Why?
|
| Hydrazones | 1 | 2009 | 102 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 1994 | 663 | 0.020 |
Why?
|
| Autopsy | 1 | 1992 | 1021 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1708 | 0.020 |
Why?
|
| Alprostadil | 1 | 1988 | 89 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 12961 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 7784 | 0.020 |
Why?
|
| NF-kappa B | 3 | 2002 | 2501 | 0.020 |
Why?
|
| Phantoms, Imaging | 2 | 2007 | 2480 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1987 | 38 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2010 | 4217 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5169 | 0.020 |
Why?
|
| Glycogen | 2 | 1986 | 260 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1997 | 1564 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 1999 | 862 | 0.020 |
Why?
|
| Aortography | 1 | 1990 | 437 | 0.020 |
Why?
|
| Temperature | 1 | 1994 | 2206 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2011 | 585 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.020 |
Why?
|
| Regeneration | 1 | 2017 | 1485 | 0.020 |
Why?
|
| Technology | 1 | 2010 | 304 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 163253 | 0.020 |
Why?
|
| Disease Management | 2 | 2008 | 2458 | 0.020 |
Why?
|
| Pyridazines | 1 | 2009 | 202 | 0.020 |
Why?
|
| Cell Communication | 2 | 2006 | 1621 | 0.020 |
Why?
|
| Fetus | 1 | 2015 | 1880 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 690 | 0.020 |
Why?
|
| Registries | 3 | 2008 | 8090 | 0.020 |
Why?
|
| Ontario | 1 | 2008 | 383 | 0.020 |
Why?
|
| California | 1 | 2011 | 1402 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1987 | 300 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 4156 | 0.020 |
Why?
|
| Kidney | 2 | 2021 | 7183 | 0.020 |
Why?
|
| Heart Injuries | 1 | 1989 | 209 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2009 | 961 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 569 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1988 | 719 | 0.020 |
Why?
|
| Survivors | 2 | 2011 | 2291 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2021 | 12207 | 0.020 |
Why?
|
| PAX7 Transcription Factor | 1 | 2006 | 53 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1987 | 157 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 759 | 0.020 |
Why?
|
| Consensus | 1 | 2016 | 2958 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 656 | 0.020 |
Why?
|
| Tachycardia | 1 | 1989 | 620 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1987 | 264 | 0.020 |
Why?
|
| Survival | 1 | 2007 | 163 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 844 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16687 | 0.020 |
Why?
|
| Desmin | 1 | 2006 | 130 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1736 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1987 | 434 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 817 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2006 | 136 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1541 | 0.020 |
Why?
|
| Hirudins | 1 | 2006 | 183 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 1284 | 0.020 |
Why?
|
| Polymers | 1 | 2012 | 1620 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2009 | 1147 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2266 | 0.020 |
Why?
|
| Microvessels | 1 | 2009 | 544 | 0.020 |
Why?
|
| Dystrophin | 1 | 2006 | 285 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2010 | 1200 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 972 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1854 | 0.020 |
Why?
|
| DNA Replication | 1 | 2011 | 1399 | 0.020 |
Why?
|
| Connexins | 1 | 2006 | 360 | 0.020 |
Why?
|
| Surface Properties | 1 | 1987 | 1184 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3674 | 0.020 |
Why?
|
| Cross-Sectional Studies | 4 | 2006 | 25043 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1986 | 402 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7179 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 4026 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 940 | 0.010 |
Why?
|
| Thrombin | 1 | 2006 | 598 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3921 | 0.010 |
Why?
|
| Pyrazines | 2 | 2000 | 1231 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1751 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2009 | 14556 | 0.010 |
Why?
|
| Electric Countershock | 1 | 2006 | 534 | 0.010 |
Why?
|
| Factor X | 1 | 2003 | 64 | 0.010 |
Why?
|
| Fetal Death | 1 | 2005 | 447 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3871 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 2006 | 371 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.010 |
Why?
|
| Exercise Test | 1 | 2011 | 2075 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 152 | 0.010 |
Why?
|
| Antithrombin III | 1 | 2003 | 128 | 0.010 |
Why?
|
| Professional Competence | 1 | 2006 | 448 | 0.010 |
Why?
|
| Protein C | 1 | 2003 | 138 | 0.010 |
Why?
|
| Factor VII | 1 | 2003 | 139 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2003 | 147 | 0.010 |
Why?
|
| Prothrombin | 1 | 2003 | 185 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 642 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1114 | 0.010 |
Why?
|
| Iliac Vein | 1 | 1983 | 72 | 0.010 |
Why?
|
| Factor V | 1 | 2003 | 178 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2004 | 468 | 0.010 |
Why?
|
| Polyurethanes | 1 | 1983 | 107 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 696 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 840 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1628 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 2003 | 186 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2002 | 206 | 0.010 |
Why?
|
| Detergents | 1 | 2002 | 230 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2003 | 447 | 0.010 |
Why?
|
| Gadolinium | 1 | 2007 | 952 | 0.010 |
Why?
|
| Membranes | 1 | 2001 | 173 | 0.010 |
Why?
|
| Risk | 1 | 2014 | 9685 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 5615 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 329 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2002 | 301 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 2000 | 1676 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2001 | 92 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2009 | 3913 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 18116 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2001 | 254 | 0.010 |
Why?
|
| Myofibrils | 1 | 2001 | 146 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 1987 | 875 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3842 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 607 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2015 | 4289 | 0.010 |
Why?
|
| Movement | 1 | 2008 | 1471 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2005 | 12035 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3201 | 0.010 |
Why?
|
| Sepsis | 1 | 1994 | 2593 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2014 | 2758 | 0.010 |
Why?
|
| Delivery of Health Care | 2 | 2008 | 5319 | 0.010 |
Why?
|
| Graft Survival | 1 | 1991 | 3740 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 1236 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2009 | 2258 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 2867 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 611 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 834 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1999 | 377 | 0.010 |
Why?
|
| Boron Compounds | 1 | 2001 | 178 | 0.010 |
Why?
|
| Emergencies | 1 | 2006 | 1170 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 2001 | 410 | 0.010 |
Why?
|
| Hemorheology | 1 | 1999 | 145 | 0.010 |
Why?
|
| Dobutamine | 1 | 1999 | 123 | 0.010 |
Why?
|
| Rats, Inbred ACI | 1 | 1998 | 44 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2000 | 320 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2002 | 886 | 0.010 |
Why?
|
| Angioplasty | 1 | 2002 | 364 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 2000 | 201 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 2000 | 317 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3778 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 538 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2002 | 1155 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 1999 | 200 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5881 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6461 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5974 | 0.010 |
Why?
|
| Vero Cells | 1 | 1998 | 485 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Contrast Media | 1 | 2010 | 5300 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1989 | 3461 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4407 | 0.010 |
Why?
|
| Macrophages | 2 | 2002 | 5657 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1296 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6172 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1999 | 351 | 0.010 |
Why?
|
| Software | 1 | 2011 | 4442 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2000 | 874 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1525 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5102 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2004 | 1199 | 0.010 |
Why?
|
| Electromyography | 1 | 2000 | 1391 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 1400 | 0.010 |
Why?
|
| Lasers | 1 | 1999 | 952 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 1994 | 111 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
| Maximal Expiratory Flow Rate | 1 | 1993 | 44 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5722 | 0.010 |
Why?
|
| Indomethacin | 1 | 1994 | 331 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1998 | 1402 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 151 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1998 | 1267 | 0.010 |
Why?
|
| Guanidines | 1 | 1994 | 191 | 0.010 |
Why?
|
| Antibodies | 1 | 2001 | 2461 | 0.010 |
Why?
|
| Ion Transport | 1 | 1994 | 320 | 0.010 |
Why?
|
| Astrocytes | 1 | 2000 | 1270 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 621 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8628 | 0.010 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 1992 | 18 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 411 | 0.010 |
Why?
|
| Monitoring, Immunologic | 1 | 1991 | 100 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1950 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1993 | 926 | 0.010 |
Why?
|
| Hypertension | 2 | 1991 | 8480 | 0.010 |
Why?
|
| Brain | 1 | 1997 | 26413 | 0.010 |
Why?
|
| Vasodilation | 1 | 1994 | 944 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2000 | 2924 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2006 | 3311 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1584 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1994 | 824 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1993 | 526 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1998 | 2540 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 7799 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5523 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1998 | 3469 | 0.000 |
Why?
|
| Genome, Human | 1 | 1998 | 4420 | 0.000 |
Why?
|
| Seizures | 1 | 1997 | 2859 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8302 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9647 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1997 | 6150 | 0.000 |
Why?
|
| Neutrophils | 1 | 1993 | 3717 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 964 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 10182 | 0.000 |
Why?
|
| Mutation | 1 | 2002 | 29784 | 0.000 |
Why?
|